TREATMENT OF THYROTOXICOSIS WITH 'NEO MERCAZOLE' (2-CARBETHOXYTHIO-1-METHYLGLYOXALINE): REPORT OF 120 CASES
- 2 May 1953
- journal article
- Published by Elsevier in The Lancet
- Vol. 261 (6766) , 873-879
- https://doi.org/10.1016/s0140-6736(53)92004-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- HYPERTHYROIDISM—AN EVALUATION OF TREATMENT WITH ANTITHYROID DRUGS FOLLOWED BY SUBTOTAL THYROIDECTOMYAnnals of Internal Medicine, 1952
- PROPYLTHIOURACIL AND METHIMAZOLE THERAPYJAMA, 1952
- TREATMENT OF THYROTOXICOSIS WITH 1-METHYL-2-MERCAPTOIMIDAZOLEArchives of internal medicine (1960), 1952
- AGRANULOCYTOSIS OCCURRING DURING METHIMAZOLE ("TAPAZOLE") THERAPYJAMA, 1952
- Experience with methimazole (tapazole) in the treatment of hyperthyroidism: A report of thirty-five casesThe American Journal of Medicine, 1951
- TREATMENT OF THYROTOXICOSIS WITH 2-CARBETHOXYTHIO-1-METHYLGLYOXALINE (C.G.1)The Lancet, 1951
- l-METHYL-2-MERCAPTOIMIDAZOLE: A NEW ACTIVE ANTITHYROID AGENT*Journal of Clinical Endocrinology & Metabolism, 1951
- THE USE OF ANTITHYROID DRUGS DURING PREGNANCY*†Journal of Clinical Endocrinology & Metabolism, 1951
- ANTITHYROID ACTIVITY OF 2-CARBETHOXYTHIO- 1-METHYLGLYOXALINEThe Lancet, 1951
- INVESTIGATION OF THYROID FUNCTION AND DISEASE WITH RADIOACTIVE IODINEThe Lancet, 1950